Last updated on February 2018

Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis

Brief description of study

-Rivaroxaban is factor Xa inhibitor

Detailed Study Description

PVT is a common complication of liver cirrhosis

Clinical Study Identifier: NCT03193502

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.